BE801108A - Nouveaux composes pyridopyrrolobenzheterocycliques leur preparation et compositions pharmaceutiques les contenant - Google Patents

Nouveaux composes pyridopyrrolobenzheterocycliques leur preparation et compositions pharmaceutiques les contenant

Info

Publication number
BE801108A
BE801108A BE132425A BE132425A BE801108A BE 801108 A BE801108 A BE 801108A BE 132425 A BE132425 A BE 132425A BE 132425 A BE132425 A BE 132425A BE 801108 A BE801108 A BE 801108A
Authority
BE
Belgium
Prior art keywords
pyridopyrrolobenzheterocyclic
compounds
preparation
new
pharmaceutical compositions
Prior art date
Application number
BE132425A
Other languages
English (en)
Inventor
P Rajagopalan
Original Assignee
Endo Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Lab filed Critical Endo Lab
Publication of BE801108A publication Critical patent/BE801108A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/22—Eight-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/18—Eight-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE132425A 1972-06-19 1973-06-19 Nouveaux composes pyridopyrrolobenzheterocycliques leur preparation et compositions pharmaceutiques les contenant BE801108A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26376672A 1972-06-09 1972-06-09
US357528A US3914421A (en) 1972-06-19 1973-05-07 Pyridopyrrolobenzheterocycles for combatting depression

Publications (1)

Publication Number Publication Date
BE801108A true BE801108A (fr) 1973-10-15

Family

ID=26950035

Family Applications (1)

Application Number Title Priority Date Filing Date
BE132425A BE801108A (fr) 1972-06-19 1973-06-19 Nouveaux composes pyridopyrrolobenzheterocycliques leur preparation et compositions pharmaceutiques les contenant

Country Status (7)

Country Link
US (1) US3914421A (fr)
BE (1) BE801108A (fr)
DE (1) DE2330719A1 (fr)
FR (1) FR2189048B1 (fr)
IL (1) IL42430A0 (fr)
LU (1) LU67815A1 (fr)
NL (1) NL7308525A (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115577A (en) * 1972-06-19 1978-09-19 Endo Laboratories, Inc. Pyridopyrrolobenzheterocycles
US4183936A (en) * 1972-06-19 1980-01-15 Endo Laboratories, Inc. Pyridopyrrolobenzheterocycles
US4013652A (en) * 1972-06-19 1977-03-22 Endo Laboratories, Inc. Pyridopyrrolobenzoxazine
CH644602A5 (de) * 1978-06-05 1984-08-15 Sankyo Co Benzothiazocin- und benzothiazoninderivate, ihre herstellung und diese derivate enthaltende pharmazeutische praeparate.
US4219550A (en) * 1978-11-09 1980-08-26 E. I. Du Pont De Nemours And Company Cis- and trans- octahydropyridopyrrolobenzheterocycles
US4997831A (en) * 1988-09-01 1991-03-05 Glaxo Group Limited Lactam derivatives
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
EP0380155A1 (fr) * 1989-01-19 1990-08-01 Duphar International Research B.V Dérivés de 1,2,3,4-tétrahydro-bêta-carboline, 8,9-annelés
US6713471B1 (en) * 1999-06-15 2004-03-30 Bristol-Myers Squibb Pharma Company Substituted heterocycle fused gamma-carbolines
US7071186B2 (en) * 1999-06-15 2006-07-04 Bristol-Myers Squibb Pharma Co. Substituted heterocycle fused gamma-carbolines
AR024378A1 (es) 1999-06-15 2002-10-02 Du Pont Pharm Co Gamma-carbolinas fusionadas heterociclicas sustituidas
ES2329553T4 (es) 2000-12-20 2010-12-07 Bristol-Myers Squibb Company Pirroloquinolinas y piridoquinolinas sustituidas como agonistas y antagonistas de serotonina.
KR20030070073A (ko) * 2000-12-20 2003-08-27 브리스톨-마이어스스퀴브컴파니 세로토닌 효능제 및 길항제로서의 치환된 피리도인돌
BR0116347A (pt) 2000-12-20 2004-07-06 Bristol Myers Squibb Pharma Co Derivados pirazinoquinoxalina substituìdos como agonistas e antagonistas do receptor de serotonina
US6849619B2 (en) * 2000-12-20 2005-02-01 Bristol-Myers Squibb Company Substituted pyridoindoles as serotonin agonists and antagonists
AU2002336749A1 (en) 2001-09-21 2003-04-01 Pharmacia And Upjohn Company Tricyclic indole derivatives as 5-ht ligands
ES2364046T3 (es) * 2002-12-19 2011-08-23 Bristol-Myers Squibb Company Gamma-carbolinas tricíclicas sustituidas utilizadas como agonistas y antagonistas de los receptores de la serotonina.
CA2679754C (fr) 2007-03-12 2018-08-07 Intra-Cellular Therapies, Inc. Synthese de gamma-carbolines fusionnees a heterocycles substitues
WO2011044134A1 (fr) 2009-10-05 2011-04-14 Albany Molecular Research, Inc. Dérivés d'épiminocycloalkyl(b)indole utilisés en tant que modulateurs du récepteur de la sérotonine de sous-type 6 (5-ht6) et leurs utilisations
AU2012207335A1 (en) 2011-01-19 2013-07-25 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
JP2015514135A (ja) 2012-04-14 2015-05-18 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規組成物および方法
DK2968320T3 (da) 2013-03-15 2021-02-01 Intra Cellular Therapies Inc Organiske forbindelser
CA3148303C (fr) 2013-12-03 2024-02-27 Intra-Cellular Therapies, Inc. Composes de gamma-carboline fusionnes heterocycliques pour l'utilisation dans le traitement des troubles bipolaires
CA2944755A1 (fr) 2014-04-04 2015-10-08 Intra-Cellular Therapies, Inc. Composes organiques
CA2944512C (fr) 2014-04-04 2018-04-24 Intra-Cellular Therapies, Inc. Carbolines gamma fusionnees heterocycliques destinees au traitement de troubles du systeme nerveux central
PT3407888T (pt) 2016-01-26 2021-03-19 Intra Cellular Therapies Inc Compostos de piridopirroloquinoxalina, suas composições e utilizações
SI3407889T1 (sl) 2016-03-25 2021-09-30 Intra-Cellular Therapies, Inc. Organske spojine in njihova uporaba v zdravljenju ali preprečevanju motenj centralnega živčnega sistema
EP3436455A4 (fr) 2016-03-28 2019-09-04 Intra-Cellular Therapies, Inc. Nouveaux sels et cristaux
EP3436016B1 (fr) 2016-03-28 2022-04-27 Intra-Cellular Therapies, Inc. Nouveaux co-cristaux
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
JP7013454B2 (ja) 2016-10-12 2022-02-15 イントラ－セルラー・セラピーズ・インコーポレイテッド アモルファス固体分散体
WO2018126143A1 (fr) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Composés organiques
WO2018126140A1 (fr) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Composés organiques
IL304026B2 (en) 2017-03-24 2024-11-01 Intra Cellular Therapies Inc A pharmaceutical preparation containing 1-(4-fluoro-phenyl)-4-((Sa10,Rb6)-3-D2-2,2-methyl-2, 3, a10, 10, 9, b6- hexahydro-H7, H1- Pyrido[3',4',:4,5]pyrrolo[3,2,1-de]quioxalin-8-yl)-butan-1-one and its uses
US11427587B2 (en) 2017-07-26 2022-08-30 Intra-Cellular Therapies, Inc. Organic compounds
JP7223742B2 (ja) 2017-07-26 2023-02-16 イントラ－セルラー・セラピーズ・インコーポレイテッド 有機化合物
IL277504B1 (en) 2018-03-23 2026-02-01 Intra Cellular Therapies Inc Deuterium-converted ((sa10,rb6)-8-(3-(4-fluorophenoxy)propyl 6b, 7, 8, 9, 10, 10a-hexahydro-1h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-82(h3)-one compounds, pharmaceutical composition containing them and their uses
JP7476115B2 (ja) 2018-06-06 2024-04-30 イントラ－セルラー・セラピーズ・インコーポレイテッド 新規の塩および結晶
WO2019237037A1 (fr) 2018-06-08 2019-12-12 Intra-Cellular Therapies, Inc. Nouvelles méthodes
DK3609891T3 (da) 2018-06-11 2026-02-23 Intra Cellular Therapies Inc Syntese af substituerede heterocykliske fusionerede gamma-carboliner
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
AU2019328528B2 (en) 2018-08-31 2025-01-23 Intra-Cellular Therapies, Inc. Novel methods
MX2021002321A (es) 2018-08-31 2021-04-28 Intra Cellular Therapies Inc Nuevos metodos.
CN114072150A (zh) 2019-07-07 2022-02-18 细胞内治疗公司 新方法
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH307223A (de) * 1952-04-28 1955-05-15 Bayer Ag Verfahren zur Herstellung eines Derivates des Tetrahydro-y-carbolins.

Also Published As

Publication number Publication date
FR2189048A1 (fr) 1974-01-25
LU67815A1 (fr) 1973-09-26
NL7308525A (fr) 1973-12-21
US3914421A (en) 1975-10-21
FR2189048B1 (fr) 1976-10-22
DE2330719A1 (de) 1974-01-10
IL42430A0 (en) 1973-08-29

Similar Documents

Publication Publication Date Title
BE771493A (fr) Nouveaux derives de l'isoindoline, leur preparation et les compositionsqui les contiennent
BE826709A (fr) Nouveaux composes heterocycliques, leur preparation et medicament les contenant
FR2347365A1 (fr) Trans-hexahydro-pyrido-indoles, leur preparation et compositions pharmaceutiques les contenant
BE764660A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
BE764659A (fr) Nouveaux derives de l'indole, leur preparation et medicaments contenantces derives
FR2283686A1 (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant
BE776682A (fr) Nouveaux derives de l'isoindoline, leur preparation et les compositionsmedicinales qui les contiennent
BE746301A (fr) Nouveaux benzylimidazoles alpha, alpha-disubstitues, leur procede de preparation et compositions pharmaceutiques les contenant
BE796828A (fr) Nouveaux derives de l'isoindoline leur preparation et les compositions medicinales qui les contiennent
BE777911A (fr) Nouveaux composes heterocycliques, leur preparation et compositions pharmaceutiques les contenant
BE800311A (fr) Aminohalopyridines substituees, leur preparation et compositions en contenant
FR2290193A1 (fr) Derives de n2-naphtalenesulfonyl-l-arginine, leur preparation et compositions pharmaceutiques les contenant
BE848227A (fr) Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant,
BE803474A (fr) Nouvelles 2-alkylamino-dihydropyridines, leur procede de preparation et compositions pharmaceutiques les contenant
BE806854A (fr) Nouvelles urees tricycliques, leur preparation et les compositions pharmaceutiques en contenant
BE786031A (fr) Nouveaux derives de la phenanthridine, leur preparation et les compositions medicinales qui les contiennent
FR2340310A1 (fr) Hydrazinophtalazines substituees, leur preparation et compositions pharmaceutiques les contenant
BE775294A (fr) Nouveaux derives de la pyridazine, leur preparation et medicaments les contenant
FR2310132A1 (fr) 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant
BE832121A (fr) Nouveaux composes anti-arythmiques et compositions pharmaceutiques les contenant
BE793851A (fr) Nouveaux derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
BE808094A (fr) Nouveaux derives de propanolamine et composition pharmaceutique les contenant
BE761713A (fr) Nouvelles pyrrolidines substituees, leur preparation et compositions pharmaceutiques les contenant
BE778564A (fr) Nouveaux esters d'ara-cytidine, leur preparation et compositions pharmaceutiques les contenant
BE872955A (fr) Composes polyfluorohydroxyisopropyl carbostyriles tricycliques antihypertensifs, leur preparation et compositions pharmaceutiques les contenant